concanavalin-a and Neuromuscular-Diseases

Stimulation of lymphocytes from motor neurone disease patients by either concanavalin A or PHA was shown to be significantly depressed relative to that from normal controls, as assayed by incorporation of [3H]thymidine or [3H]leucine or by glucose uptake. Corresponding significant differences were not shown by assays based upon incorporation of [3H]uridine or of lactate release. Lymphocytes from 4 out of 14 motor neurone disease patients showed a blastogenic response to membranes from rat spinal cord cells, compared with those from 0 out of 9 normal controls. These results not only suggest the possibility of an impaired cellular immune control in MND patients but also indicate the presence of lymphocytes sensitised specifically to neuronal membrane components.

Topics: Adult; Aged; Animals; Cell Membrane; Cells, Cultured; Concanavalin A; Dose-Response Relationship, Drug; Female; Glucose; Humans; Lactates; Lactic Acid; Lymphocytes; Male; Middle Aged; Mitogens; Motor Neurons; Neuromuscular Diseases; Neurons; Nucleic Acids; Phytohemagglutinins; Rats; Spinal Cord; Time Factors